R&D/Clinical Trials

>

Latest News

Study Finds Varenicline Significantly Boosts Vaping Cessation Rates in Youth
Study Finds Varenicline Significantly Boosts Vaping Cessation Rates in Youth

April 24th 2025

A new study shows that varenicline combined with brief remote counseling significantly improves vaping abstinence in in patients between 16 and 25 years of age.

Akeso’s PD-1/VEGF Bispecific Antibody Demonstrates Meaningful Progression-Free Survival Benefits in Advanced Squamous NSCLC
Akeso’s PD-1/VEGF Bispecific Antibody Demonstrates Meaningful Progression-Free Survival Benefits in Advanced Squamous NSCLC

April 23rd 2025

Sebela’s Novel Potassium-Competitive Acid Blocker Demonstrates Promise in Gastroesophageal Reflux Disease
Sebela’s Novel Potassium-Competitive Acid Blocker Demonstrates Promise in Gastroesophageal Reflux Disease

April 23rd 2025

Bristol Myers Squibb’s Cobenfy Falls Short in Phase III Trial as Add On Therapy for Schizophrenia
Bristol Myers Squibb’s Cobenfy Falls Short in Phase III Trial as Add On Therapy for Schizophrenia

April 23rd 2025

Johnson & Johnson’s Novel Intravesical Gemcitabine Shows Durable Response in BCG-Unresponsive Bladder Cancer
Johnson & Johnson’s Novel Intravesical Gemcitabine Shows Durable Response in BCG-Unresponsive Bladder Cancer

April 22nd 2025

Video Interviews
Podcasts

More News